Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Doximity Inc ha un obiettivo di prezzo di consenso pari a $67.53, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da Baird, Piper Sandler y Canaccord Genuity il septiembre 11, 2025, agosto 11, 2025 y agosto 8, 2025. Con un obiettivo di prezzo medio di $69.33 tra le Baird, Piper Sandler y Canaccord Genuity, c'è un implicito -2.70% downside per Doximity Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Baird
Piper Sandler
Canaccord Genuity
Raymond James
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Doximity
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/11/2025 | 12.26% | Baird | $75 → $80 | Maintains | Outperform | |||
08/11/2025 | -3.17% | Piper Sandler | $65 → $69 | Maintains | Overweight | |||
08/08/2025 | -17.2% | Canaccord Genuity | $50 → $59 | Maintains | Hold | |||
08/08/2025 | 5.25% | Raymond James | $65 → $75 | Maintains | Outperform | |||
08/08/2025 | -8.78% | Wells Fargo | $62 → $65 | Maintains | Equal-Weight | |||
08/08/2025 | 5.25% | Needham | $67 → $75 | Maintains | Buy | |||
08/04/2025 | -12.99% | Wells Fargo | $55 → $62 | Maintains | Equal-Weight | |||
07/17/2025 | -14.4% | Truist Securities | $52 → $61 | Maintains | Hold | |||
07/14/2025 | -1.77% | Keybanc | $65 → $70 | Maintains | Overweight | |||
07/09/2025 | -1.77% | Evercore ISI Group | $50 → $70 | Upgrade | In-Line → Outperform | |||
06/25/2025 | -12.99% | B of A Securities | $55 → $62 | Maintains | Neutral | |||
06/02/2025 | 12.26% | BTIG | $80 → $80 | Upgrade | Neutral → Buy | |||
05/27/2025 | -15.8% | JP Morgan | $63 → $60 | Maintains | Neutral | |||
05/21/2025 | -29.83% | Goldman Sachs | $80 → $50 | Maintains | Neutral | |||
05/20/2025 | -8.78% | Baird | $87 → $65 | Maintains | Outperform | |||
05/16/2025 | -15.8% | Mizuho | $65 → $60 | Maintains | Neutral | |||
05/16/2025 | -27.03% | Truist Securities | $58 → $52 | Maintains | Hold | |||
05/16/2025 | -8.78% | Raymond James | $83 → $65 | Maintains | Outperform | |||
05/16/2025 | -29.83% | Canaccord Genuity | $71 → $50 | Maintains | Hold | |||
05/16/2025 | -5.98% | Needham | $82 → $67 | Maintains | Buy | |||
04/24/2025 | -15.8% | Morgan Stanley | $71 → $60 | Maintains | Equal-Weight | |||
04/16/2025 | -1.77% | Keybanc | $83 → $70 | Maintains | Overweight | |||
04/10/2025 | -18.61% | Truist Securities | $65 → $58 | Maintains | Hold | |||
02/18/2025 | 22.09% | Baird | $61 → $87 | Maintains | Outperform | |||
02/14/2025 | -11.59% | JP Morgan | $48 → $63 | Maintains | Neutral | |||
02/10/2025 | -8.78% | Mizuho | $55 → $65 | Maintains | Neutral | |||
02/10/2025 | 12.26% | Goldman Sachs | $58 → $80 | Maintains | Neutral | |||
02/07/2025 | 26.3% | Leerink Partners | $60 → $90 | Upgrade | Market Perform → Outperform | |||
02/07/2025 | -0.36% | Canaccord Genuity | $60 → $71 | Maintains | Hold | |||
02/07/2025 | 16.47% | Raymond James | $65 → $83 | Reiterates | Outperform → Outperform | |||
02/07/2025 | -22.82% | Wells Fargo | $43 → $55 | Maintains | Equal-Weight | |||
02/07/2025 | 15.07% | Needham | $65 → $82 | Maintains | Buy | |||
01/13/2025 | -39.66% | Wells Fargo | $41 → $43 | Maintains | Equal-Weight | |||
01/08/2025 | -8.78% | Keybanc | $70 → $65 | Maintains | Overweight | |||
01/06/2025 | -20.01% | B of A Securities | $54 → $57 | Maintains | Neutral | |||
12/20/2024 | -22.82% | Stephens & Co. | → $55 | Initiates | → Equal-Weight | |||
12/04/2024 | -22.82% | Mizuho | → $55 | Initiates | → Neutral | |||
11/21/2024 | -32.64% | JP Morgan | $30 → $48 | Maintains | Neutral | |||
11/15/2024 | -18.61% | Goldman Sachs | → $58 | Initiates | → Neutral | |||
11/14/2024 | -31.24% | Truist Securities | $35 → $49 | Maintains | Hold | |||
11/14/2024 | -25.62% | Morgan Stanley | $33 → $53 | Upgrade | Underweight → Equal-Weight | |||
11/13/2024 | -15.8% | Canaccord Genuity | $40 → $60 | Downgrade | Buy → Hold | |||
11/11/2024 | 5.25% | Barclays | $52 → $75 | Maintains | Overweight | |||
11/08/2024 | -8.78% | Needham | $38 → $65 | Maintains | Buy | |||
11/08/2024 | -8.78% | Raymond James | $37 → $65 | Reiterates | Outperform → Outperform | |||
11/08/2024 | -42.46% | Wells Fargo | $19 → $41 | Upgrade | Underweight → Equal-Weight | |||
11/08/2024 | -1.77% | Keybanc | → $70 | Upgrade | Sector Weight → Overweight | |||
10/30/2024 | -53.69% | Morgan Stanley | $26 → $33 | Maintains | Underweight | |||
10/15/2024 | -27.03% | Barclays | $35 → $52 | Upgrade | Equal-Weight → Overweight | |||
10/14/2024 | -14.4% | Baird | $45 → $61 | Maintains | Outperform | |||
10/08/2024 | -36.85% | Evercore ISI Group | $34 → $45 | Maintains | In-Line | |||
10/07/2024 | -36.85% | B of A Securities | $32 → $45 | Maintains | Neutral | |||
09/17/2024 | -36.85% | Baird | $41 → $45 | Maintains | Outperform | |||
08/20/2024 | -43.87% | Canaccord Genuity | $37 → $40 | Maintains | Buy | |||
08/19/2024 | -57.9% | JP Morgan | $27 → $30 | Maintains | Neutral | |||
08/14/2024 | -50.88% | Truist Securities | $31 → $35 | Reiterates | Hold → Hold | |||
08/09/2024 | -52.29% | Evercore ISI Group | $29 → $34 | Maintains | In-Line | |||
08/09/2024 | -55.09% | B of A Securities | $29 → $32 | Maintains | Neutral | |||
08/09/2024 | -50.88% | Barclays | $31 → $35 | Maintains | Equal-Weight | |||
08/09/2024 | -46.67% | Needham | → $38 | Upgrade | Hold → Buy | |||
08/09/2024 | -63.51% | Morgan Stanley | $25 → $26 | Maintains | Underweight | |||
07/18/2024 | -73.34% | Wells Fargo | $27 → $19 | Downgrade | Equal-Weight → Underweight | |||
05/17/2024 | — | Needham | — | Reiterates | → Hold | |||
05/17/2024 | -59.3% | Evercore ISI Group | $28 → $29 | Maintains | In-Line | |||
04/25/2024 | -64.92% | JP Morgan | → $25 | Upgrade | Underweight → Neutral | |||
04/23/2024 | -64.92% | Morgan Stanley | $25 → $25 | Maintains | Underweight | |||
04/02/2024 | -57.9% | Evercore ISI Group | → $30 | Maintains | In-Line | |||
03/15/2024 | -64.92% | JP Morgan | $22 → $25 | Maintains | Underweight | |||
02/26/2024 | -55.09% | Leerink Partners | → $32 | Initiates | → Market Perform | |||
02/09/2024 | -57.9% | Evercore ISI Group | $29 → $30 | Maintains | In-Line | |||
02/09/2024 | -59.3% | Truist Securities | $28 → $29 | Maintains | Hold | |||
02/09/2024 | -62.11% | Wells Fargo | $25 → $27 | Maintains | Equal-Weight | |||
01/23/2024 | -55.09% | B of A Securities | $29 → $32 | Maintains | Neutral | |||
01/02/2024 | -59.3% | B of A Securities | $21 → $29 | Upgrade | Underperform → Neutral | |||
11/10/2023 | -67.72% | Piper Sandler | $21 → $23 | Maintains | Neutral | |||
11/10/2023 | -64.92% | Morgan Stanley | $21 → $25 | Maintains | Underweight | |||
09/05/2023 | -53.69% | Canaccord Genuity | $40 → $33 | Maintains | Buy | |||
08/11/2023 | -64.92% | Wells Fargo | $37 → $25 | Maintains | Equal-Weight | |||
08/09/2023 | -60.71% | Truist Securities | $33 → $28 | Maintains | Hold | |||
08/09/2023 | -70.53% | Morgan Stanley | $28 → $21 | Maintains | Underweight | |||
08/09/2023 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
08/09/2023 | -57.9% | Raymond James | $40 → $30 | Maintains | Outperform | |||
08/09/2023 | — | Needham | — | Downgrade | Buy → Hold | |||
08/03/2023 | -49.48% | Piper Sandler | $38 → $36 | Downgrade | Overweight → Neutral | |||
06/07/2023 | -43.87% | Canaccord Genuity | → $40 | Reiterates | Buy → Buy | |||
06/07/2023 | -36.85% | Needham | → $45 | Reiterates | Buy → Buy | |||
06/05/2023 | -53.69% | Truist Securities | $36 → $33 | Maintains | Hold | |||
05/17/2023 | -43.87% | Canaccord Genuity | $41 → $40 | Maintains | Buy | |||
05/17/2023 | -55.09% | Evercore ISI Group | $33 → $32 | Maintains | In-Line | |||
05/17/2023 | -60.71% | Morgan Stanley | $29 → $28 | Maintains | Underweight | |||
05/17/2023 | -36.85% | Needham | → $45 | Reiterates | Buy → Buy | |||
05/01/2023 | -48.08% | Wells Fargo | $39 → $37 | Downgrade | Overweight → Equal-Weight | |||
02/17/2023 | -57.9% | JP Morgan | $60 → $30 | Maintains | Underweight | |||
02/10/2023 | -45.27% | Wells Fargo | $44 → $39 | Maintains | Overweight | |||
02/10/2023 | -42.46% | Canaccord Genuity | $42 → $41 | Maintains | Buy | |||
02/10/2023 | -36.85% | Needham | → $45 | Reiterates | → Buy | |||
01/06/2023 | -59.3% | Morgan Stanley | $32 → $29 | Downgrade | Equal-Weight → Underweight | |||
11/11/2022 | -38.25% | Wells Fargo | $38 → $44 | Maintains | Overweight | |||
10/31/2022 | -46.67% | Wells Fargo | → $38 | Initiates | → Overweight | |||
10/24/2022 | -60.71% | Evercore ISI Group | → $28 | Initiates | → In-Line |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Doximity (DOCS)?
El último precio objetivo de Doximity (NYSE:DOCS) fue comunicado por Baird el septiembre 11, 2025. La firma de analistas fijó un precio objetivo para $80.00 que espera DOCS a rise dentro de 12 meses (un posible 12.26% upside). 53 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Doximity (DOCS)?
La última calificación de analistas para Doximity (NYSE:DOCS) fue proporcionada por Baird, y Doximity mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Doximity (DOCS)?
La última revisión al alza de Doximity Inc se produjo en julio 9, 2025, cuando Evercore ISI Group elevó su precio objetivo a $70. Evercore ISI Group anteriormente tenía an in-line para Doximity Inc.
¿Cuándo fue la última revisión a la baja de Doximity (DOCS)?
La última revisión a la baja de Doximity Inc se produjo en noviembre 13, 2024, cuando Canaccord Genuity cambió su precio objetivo de $40 a $60 para Doximity Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Doximity (DOCS)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Doximity, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Doximity se registró el septiembre 11, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 11, 2026.
¿Es correcta la calificación de los analistas sobre Doximity (DOCS)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Doximity (DOCS) fue un mantuvo con un precio objetivo de $75.00 a $80.00. El precio actual al que cotiza Doximity (DOCS) es de $71.26, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.